The biopsy guidance system market is projected to grow from USD 542.4 million in 2025 to USD 953.2 million by 2035, at a CAGR of 5.8%. Ultrasound Guided Biopsy will dominate with a 46.2% market share, while breast biopsy will lead the application segment with a 54.8% share.